~53 spots leftby Mar 2029

Sleep Stability Intervention for Type 1 Diabetes

Recruiting in Palo Alto (17 mi)
Age: 18 - 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Illinois at Chicago
No Placebo Group

Trial Summary

What is the purpose of this trial?

People with type 1 diabetes are disproportionately affected by cardiovascular disease (CVD). Short and irregular sleep have been associated with cardiovascular risk in this population. Improving sleep regularity has been associated with improved glycemic markers however mechanisms by which improving sleep regularity improves metabolic and cardiovascular health is not known. The investigators propose to conduct a mechanistic study using a sleep stability manipulation. This proposal will advance the understanding of mechanisms by which improving sleep regularity influences glycemic control and cardiovascular risk in T1D.

Research Team

Eligibility Criteria

This trial is for individuals with type 1 diabetes who may be experiencing cardiovascular issues due to irregular or insufficient sleep. The study aims to understand how stabilizing sleep patterns can improve heart health and blood sugar control in these patients.

Inclusion Criteria

Report habitual sleep irregularity ≥1 hour/week
I am between 18 and 50 years old and was diagnosed with Type 1 Diabetes over a year ago.
I want to sleep better and I own a smartphone.

Exclusion Criteria

Insomnia symptoms defined as Insomnia Severity Index score ≥15
Rotating shift or night work or routinely sleeping after 3 AM
Pregnant, breast feeding, or planning pregnancy
See 6 more

Treatment Details

Interventions

  • Sleep stability intervention (Behavioral Intervention)
Trial OverviewThe intervention being tested is a 'sleep stability' program designed to help participants achieve more regular and consistent sleep patterns, which could potentially lead to better management of their diabetes and reduced risk of cardiovascular disease.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Single armExperimental Treatment1 Intervention
Sleep stability intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+
Mark I. Rosenblatt profile image

Mark I. Rosenblatt

University of Illinois at Chicago

Chief Executive Officer

MD, PhD, MBA, MHA

Jon Radosta profile image

Jon Radosta

University of Illinois at Chicago

Chief Medical Officer since 2023

MD

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+
Dr. Jeanne Marrazzo profile image

Dr. Jeanne Marrazzo

National Institutes of Health (NIH)

Chief Medical Officer

MD from University of California, Los Angeles

Dr. Jay Bhattacharya profile image

Dr. Jay Bhattacharya

National Institutes of Health (NIH)

Chief Executive Officer

MD, PhD from Stanford University

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+
Dr. Gary H. Gibbons profile image

Dr. Gary H. Gibbons

National Heart, Lung, and Blood Institute (NHLBI)

Chief Executive Officer since 2012

MD from Harvard Medical School

Dr. James P. Kiley profile image

Dr. James P. Kiley

National Heart, Lung, and Blood Institute (NHLBI)

Chief Medical Officer since 2011

MD from University of California, San Francisco